Burning Rock Biotech (BNR) Invested Capital (2020 - 2024)
Historic Invested Capital for Burning Rock Biotech (BNR) over the last 6 years, with Q2 2025 value amounting to $28000.0.
- Burning Rock Biotech's Invested Capital changed N/A to $28000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $28000.0, marking a year-over-year change of. This contributed to the annual value of $79.6 million for FY2024, which is 2647.63% down from last year.
- Per Burning Rock Biotech's latest filing, its Invested Capital stood at $28000.0 for Q2 2025.
- In the past 5 years, Burning Rock Biotech's Invested Capital registered a high of $289.9 million during Q4 2021, and its lowest value of $28000.0 during Q2 2025.
- Its 5-year average for Invested Capital is $108.7 million, with a median of $93.9 million in 2023.
- In the last 5 years, Burning Rock Biotech's Invested Capital plummeted by 9877.79% in 2021 and then skyrocketed by 448366.56% in 2022.
- Burning Rock Biotech's Invested Capital (Quarter) stood at $289.9 million in 2021, then tumbled by 42.08% to $167.9 million in 2022, then plummeted by 35.56% to $108.2 million in 2023, then fell by 26.48% to $79.6 million in 2024, then crashed by 99.96% to $28000.0 in 2025.
- Its Invested Capital stands at $28000.0 for Q2 2025, versus $79.6 million for Q4 2024 and $108.2 million for Q4 2023.